Description of impactThe American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the prior position statements, published in 2012 and 2015, on the management of type 2 diabetes in adults. A systematic evaluation of the literature since 2014 informed new recommendations. Metformin review included in statement in relation to cardiovascular outcomes.
|Impact date||5 Oct 2018|
|Category of impact||Health impacts|
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes
Research output: Contribution to journal › Review article › peer-review